Latest Revenue Guidance News

Page 16 of 30
PEXA Group has announced its strategic exit from majority-owned Digital Solutions businesses, triggering a $26 million impairment and a restatement of its FY26 financial guidance. The move signals a sharper focus on core operations amid restructuring costs.
Sophie Babbage
Sophie Babbage
16 Feb 2026
AVITA Medical closed 2025 with steady revenue growth and over 80% gross margin, setting the stage for a confident revenue forecast of up to US$85 million in 2026. The company also secured a new debt facility with improved terms, underpinning its growth ambitions.
Ada Torres
Ada Torres
13 Feb 2026
AVITA Medical reported steady Q4 losses amid reimbursement challenges but achieved 11% revenue growth for 2025 and secured a $60 million credit facility to fuel future expansion.
Ada Torres
Ada Torres
13 Feb 2026
Amaero Ltd reported a remarkable 367% revenue increase to A$7.76 million for H1 FY2026, supported by a $50 million capital raise and exclusive supply agreements with industry leaders. Despite widening losses, the company is accelerating capacity expansion and securing key partnerships in aerospace and defence.
Victor Sage
Victor Sage
13 Feb 2026
Bravura Solutions has raised its FY26 revenue and cash EBITDA guidance, reflecting robust project engagement and disciplined cost management. The company also plans increased investment in internal technology.
Sophie Babbage
Sophie Babbage
9 Feb 2026
SKS Technologies Group has upgraded its FY26 earnings forecast following $60 million in new contract awards, including major projects for NEXTDC and Ernst & Young. The company anticipates stronger revenue and profit margins driven by robust demand in data centre infrastructure.
Sophie Babbage
Sophie Babbage
5 Feb 2026
Jcurve Solutions has reported a robust Q2FY26 with a significant profit turnaround and a confident revenue outlook for FY26, driven by strong sales and recurring revenue growth.
Sophie Babbage
Sophie Babbage
5 Feb 2026
Jcurve Solutions has reported a robust first half of FY26, posting a 32% increase in revenue and a remarkable 478% jump in EBITDA, while upgrading its full-year revenue guidance amid ongoing customer churn challenges.
Sophie Babbage
Sophie Babbage
5 Feb 2026
Aroa Biosurgery’s latest business update reveals promising clinical outcomes from its Myriad trauma study and evolving reimbursement policies that could reshape its market position. The company also projects solid revenue growth for FY26, supported by strategic commercial initiatives.
Ada Torres
Ada Torres
3 Feb 2026
Aroa Biosurgery reaffirms strong FY26 guidance, buoyed by favourable US Medicare reimbursement for Symphony and promising trauma study results for Myriad.
Ada Torres
Ada Torres
3 Feb 2026
Weebit Nano has landed its largest customer yet with Texas Instruments licensing its ReRAM technology, while achieving key technical milestones and doubling its revenue guidance for FY26.
Sophie Babbage
Sophie Babbage
30 Jan 2026
Cann Group Limited has reported its first-ever free cash flow positive quarter, following a significant debt restructuring and a $9 million capital raise. Despite a softer quarterly revenue, the company is advancing new product launches and export partnerships, positioning itself for growth.
Ada Torres
Ada Torres
30 Jan 2026

Browse the archive

Full archive